Biogen pays $1.25 billion to protect a blockbuster drug
Wednesday, January 18, 2017 - 15:21
in Mathematics & Economics
Licensing agreement with Forward Pharma will ensure rights to the multiple sclerosis drug Tecfidera
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via